The author discusses the possible clinical applications of electrically coupling non-oscillating cells as a means of generating oscillatory network behavior. In essence, this dynamic mechanism impacts electrical synapses, essential in the generation of oscillatory activity in the inferior olive or IO. Specifically, this action may manifest as tremor in which, the IO has been directly implicated. This study provides evidence for the role of IO function (olivary gap-junctions) in tremor generation, a profound disabling pathology affecting millions of people worldwide.
This article provides an added basis for understanding the mechanisms involved in promoting the early-stage effects of Alzheimer's disease. The author discusses the results of new studies that impact our knowledge of apoE and the role it plays in contributing to Alzheimer's and CAA (cerebral amyloid angiopathy); particularly, how different apoE isoforms appear to differentially confer risk for those developing Alzheimer's disease.
REVIEW ARTICLE Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain M Bauer, A Heinz, PC Whybrow
This article examines the role of the thyroid in its interaction with monoamine neurotransmitter systems as an alternate means of underlying action. A review of literature focused on the connection between adult human/animal thyroid hormones and serotonin is presented. Evidence suggests strongly that thyroid action creates a modulating effect on the 5-HT serotonin system. The authors posit that one mechanism in particular, an increase in serotonergic neurotransmission, may be responsible for the modulatory effects of thyroid hormones in affective illness. This study increases our knowledge of linkage disequilibrium (LD) and its complex structure across genes. Research studies focused on the dopamine transporter gene (DAT) rely heavily on linkage disequilibrium as a means of assessing the possible genetic contribution of DAT in the development of disorders such as bipolar, ADHD, cocaine-induced paranoia, Tourette's syndrome and Parkinson's disease. Moreover, a clearer understanding of LD directly impacts the accurate interpretation of research results that may potentially facilitate the mapping of precise functional variants. These analyses thus reveal an intricate structure resulting from both gene recombination and mutation, knowledge which may prove invaluable in the design and results of future experimental research.
ORIGINAL RESEARCH ARTICLES
Epi-inositol regulates expression of the yeast IN01 gene encoding inositol-1-P sythase A Shaldubina, S Ju, DL Vaden, D Ding, RH Belmaker, ML Greenberg This study suggests that the behavioral effects of epiinositol in certain psychiatric disorders are similar to those known for myo-inositol and may likewise, prove effective in human clinical trials. The authors postulate that the behavioral effects of epi-inositol may be attributed to gene expression. Results show that epi-inositol affects regulation of expression of the INO1 gene and like myo-inositol, causes a significant reduction in INO1 expression. However, this study demonstrates that epi-inositol does not affect regulation of INM1, the expression of which is up-regulated by myo-inositol. It is believed that the observed regulatory effects of epiinositol may help explain how this inositol isomer exerts behavioral effects without being incorporated into phosphatidylinositol.
In vitro biotransformation of the selective serotonin reuptake inhibitor citalopram, its enantiomers and demethylated metabolites by monoamine oxidase in rat and human brain preparations M Kosel, C Gnerre, P Voirol, M Amey, B Rochat, C Bouras, B Testa, P Baumann This study identifies enzyme systems that catalyze the local cerebral metabolism of citalopram, a widely used selective serotonin reuptake inhibitor (SSRI) antidepressant. Research results demonstrate that the metabolism of citalopram in rat brain microsomes and in rat and human brain mitochondria are in the same range as they are for serotonin and dopamine metabolism by monoamine oxidases. Thus, the biotransformation of citalopram in the rat and human brain occurs mainly through monoamine oxidases and not, as in the liver, through cytochrome P-450.
The Wellcome trust UK-Irish bipolar affective disorder sibling-pair genome screen: first stage report P Bennett, R Segurado, I Jones, S Bort, F McCandless, D Lambert, J Heron, C Comerford, F Middle, A Corvin, G Pelios, G Kirov, B Larsen, T Mulchay, N Williams, R O'Connell, E O'Mahony, A Payne, M Owen, P Holmans, N Craddock and M Gill This article reports the first stage of a two-stage genome wide screen designed to identify chromosomal regions that may harbor susceptibility genes for bipolar affective disorder. The first stage screening sample consisted of 509 subjects from 151 nuclear families recruited from within the United Kingdom and the Republic of Ireland. This sample contained 154 narrowly defined affected sibling pairs and 258 broadly defined affected sibling pairs, of which approximately two-thirds of all families contained at least one other additional typed individual. All persons were genotyped using 398 highly polymorphic microsatellite markers. Analysis of these data found no evidence for loci of major effect and no regions reached genome-wide significance for either suggestive or significant linkage. The authors identified 19 points across the genome where the MLS exceeded a value set for follow-up in second-stage screening. Some points overlapped with previous linkage reports, both within bipolar affective disorder and other psychiatric illnesses. This article presents results of a research study testing the genetic contribution of gamma amino butyric acid receptor 3 (GABRA3) gene as a potential candidate gene in the development of bipolar affective disorder (BPAD). GABRA3 dinucleotide polymorphism was tested in a European multicentric case-control sample, matched for sex and ethnogeographical origin. Allele and genotype (in females) frequencies were compared in 185 BPAD patients and in 370 control participants. Data suggest that the GABRA3 polymorphism may confer susceptibility to or may be in linkage disequilibrium with another gene involved in the genetic etiology of BPAD.
Excess of allele1 for

cAMP signaling pathway in depressed patients with psychotic features J Perez, D Tardito, G Racagni, E Smeraldi
This article examines abnormalities in protein kinase A (PKA) and Rap1 recently reported in depressed patients, investigating the levels of these proteins in platelets from untreated unipolar and bipolar depressed patients with psychotic features. The levels PKA and Rap1 were assessed by Western blot analysis and immunostaining in 37 drug-free patients and 29 healthy subjects. Both unipolar and bipolar patients with psychotic depression have significantly lower levels of platelet regulatory type I and higher levels of catalytic subunits of PKA than controls, whereas the levels of regulatory type II were higher only in psychotic unipolar patients. No significant differences were found in the immunolabeling of both Rap1 and actin among groups. These findings support the idea that besides nonpsychotic depression, abnormalities of PKA could be linked, albeit in a somewhat different way, with psychotic depression.
Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion FA Moreno, DC Rowe, B Kaiser, D Chase, T Michaels, J Gelernter, PL Delgado
This study investigates the relationhip between depressive symptom response during tryptophan (TRP) depletion and a functional polymorphism of the promoter region of the serotonin (5-HT) transporter gene (SLC6A4). Forty-three subjects in remission from a major depressive episode who underwent TRP depletion were genotyped. DNA was extracted from blood lymphocytes or from cheek cells. Depressive symptoms were measured with the 25-item Hamilton Depression Rating Scale (HDRS). Data indicate that individuals whose genotype predicted increased 5-HT transporter activity may be more susceptible to depressive changes in response to transient 5-HT perturbations. The use of endophenotypic markers for affective disorders such as mood response to TRP depletion may facilitate studies of complex genetic traits such as depression by decreasing its heterogeneity. S Jamain, H Quach, L Quintana-Murci, C Betancur, A Philippe, C Gillberg, E Sponheim, O H Skjeldal, M Fellous, M Leboyer, T Bourgeron This article examines the well-recognized gender difference of male predisposition to autism and the role of sex chromosomes in the development of autistic disorder. In this study, the authors searched for a specific Y chromosome effect in autistic subjects. Using informative Y-polymorphic markers, the Y chromosome haplotypes of 111 autistic subjects from France, Sweden and Norway were defined and compared with relevant control populations. No significant difference in Y-haplotype distribution between the affected and control groups were observed. Although this study cannot exclude the presence of a Y susceptibility gene, these results are not suggestive of a Y chromosome effect in autism.
Y chromosome haplogroups in autistic subjects
Exclusion of the neuronal nicotinic acetylcholine receptor ␣7 subunit gene as a candidate for catatonic schizophrenia in a large family supporting the chromosome 15q13-22 locus J Meyer, G Ortega, K Schraut, G Nü rnberg, F Rü schendorf, K Saar, R Mö ssner, TF Wienker, A Reis, G Stö ber, KP Lesch Research results provide strong evidence that a gene located telomeric to the gene encoding the neuronal nicotinic acetylcholine receptor ␣7 subunit (CHRNA7) Molecular Psychiatry may be causative for the pathogenesis of catatonic schizophrenia. This region located on chromosome 15q13.2, has been implicated in the etiopathogenesis of schizophrenia combined with neurophysiological deficit, lithium-responsive bipolar disorder and familial catatonic schizophrenia (periodic catatonia). Members of a large family with periodic catatonia strongly supporting the chromosome 15q13-22 region were genotyped with polymorphic markers localized around the CHRNA7 locus. A recombination event distally of marker D15S144 leading to the exclusion of the CHRNA7 locus from this candidate region was detected in one branch of the pedigree. Thus, this gene located telomeric to CHRNA7 proved causative for catatonic schizophrenia in this particular family. This article examines the frequency of the AA genotype and A allele in several groups of substance-dependent cases-unrestricted controls and super controls screened for the use of alcohol and cigarettes. Genetic association studies investigating the role of the +118A allele of the human -opioid receptor gene in risk for alcohol dependency have produced inconsistent findings, possibly because of the failure to recognize sampling methodology difficulties inherent in association studies of polygenic disorders. Results of this study suggest that the OPRM1 +118 polymorphism is a general risk gene for substance dependence, not specific to any particular substance. The nature of this conferred risk is more likely expressed in the use of multiple substances, detected in studies that use control samples screened for all forms of substance dependence.
